Nhat Nhat Pharmaceutical Company Report issue

For profit Phase 3
Founded: Hanoi Vietnam (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2017
NCT03216668
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Nhat Nhat Pharmaceutical Company

Active Ingredients

Drugs in Phase 3 Trials (2)

Silibinin (1 trial)

tonka bean (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Liver Failure (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2